
Nestle SA chairman Peter Brabeck says he
doesn't expect to make any acquisitions larger than $200 million to $300 million in the near term, according to Dow Jones Newswires. That dampens speculation (some of it in
this space) that the $39 billion the company will get by selling Alcon, its contact lens unit, to Novartis AG in a two-stage deal could provide the wherewithal for a larger deal.
Meanwhile, Hershey Co. shares closed Monday around 6% lower following Hershey Trust chairman LeRoy Zimmerman's pledge that the company is not for sale. In an op-ed piece published Sunday in the Harrisburg, Pa., Patriot-News, Zimmerman also said that there are other "
meaningful options" for driving growth that don't required selling the company. An international JV to boost distribution outside the U.S. seems likeliest. -
Kenneth Klee
Join Corporate Dealmaker's LinkedIn forum